CN103969447A - 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 - Google Patents
用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 Download PDFInfo
- Publication number
- CN103969447A CN103969447A CN201410216078.7A CN201410216078A CN103969447A CN 103969447 A CN103969447 A CN 103969447A CN 201410216078 A CN201410216078 A CN 201410216078A CN 103969447 A CN103969447 A CN 103969447A
- Authority
- CN
- China
- Prior art keywords
- vegf
- solution
- solid phase
- monoclonal antibody
- luminescent solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title claims abstract description 72
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title claims abstract description 71
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 title claims abstract description 62
- 239000000758 substrate Substances 0.000 title claims abstract description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 25
- 229910021538 borax Inorganic materials 0.000 claims abstract description 12
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004327 boric acid Substances 0.000 claims abstract description 12
- 239000011780 sodium chloride Substances 0.000 claims abstract description 12
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 12
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 12
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims abstract description 11
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 claims abstract description 6
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims abstract description 6
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 108090000790 Enzymes Proteins 0.000 claims description 27
- 102000004190 Enzymes Human genes 0.000 claims description 27
- 239000007790 solid phase Substances 0.000 claims description 19
- 238000012360 testing method Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 238000002372 labelling Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000009739 binding Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 4
- 239000011324 bead Substances 0.000 claims description 4
- 239000006249 magnetic particle Substances 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract 2
- 229920001213 Polysorbate 20 Polymers 0.000 abstract 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 206010028980 Neoplasm Diseases 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 8
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 102000058223 human VEGFA Human genes 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Substances [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101100372758 Danio rerio vegfaa gene Proteins 0.000 description 2
- 101150030763 Vegfa gene Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 244000191761 Sida cordifolia Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/763—Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410216078.7A CN103969447A (zh) | 2014-05-21 | 2014-05-21 | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410216078.7A CN103969447A (zh) | 2014-05-21 | 2014-05-21 | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103969447A true CN103969447A (zh) | 2014-08-06 |
Family
ID=51239197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410216078.7A Pending CN103969447A (zh) | 2014-05-21 | 2014-05-21 | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103969447A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104711279A (zh) * | 2015-03-17 | 2015-06-17 | 北京一达启航生物科技有限公司 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
CN107561287A (zh) * | 2017-08-30 | 2018-01-09 | 潍坊市康华生物技术有限公司 | 一种血管内皮细胞生长因子检测试剂盒及其制备和使用方法 |
CN108508198A (zh) * | 2018-06-21 | 2018-09-07 | 上海彧成生物科技有限公司 | 一种稳定的辣根过氧化物酶底物的配方 |
CN110082537A (zh) * | 2019-04-17 | 2019-08-02 | 迪瑞医疗科技股份有限公司 | 血管内皮生长因子化学发光免疫检测试剂盒及其制备方法 |
CN111044734A (zh) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | 一种用于检测血管内皮生长因子的检测试剂盒及其制备方法和使用方法 |
CN111808191A (zh) * | 2020-05-11 | 2020-10-23 | 廊坊天光生物技术有限公司 | 一种用于检测血清中vegf含量的抗体对及其用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368961A (zh) * | 2008-04-02 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 尿膀胱癌抗原化学发光免疫分析定量测定试剂盒及其制备方法 |
CN101368957A (zh) * | 2008-04-29 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 谷氨酸脱羧酶抗体化学发光免疫分析测定试剂盒及其制备方法 |
CN101368958A (zh) * | 2008-04-02 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 乙型肝炎病毒核心抗体IgM化学发光免疫分析测定试剂盒 |
CN102830235A (zh) * | 2012-08-28 | 2012-12-19 | 邹检平 | 一种发光检测试剂盒及其制备方法 |
CN102890083A (zh) * | 2012-09-28 | 2013-01-23 | 辽宁科骏生物有限公司 | 化学发光底物溶液和含其的试剂盒及应用其的检测方法 |
-
2014
- 2014-05-21 CN CN201410216078.7A patent/CN103969447A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101368961A (zh) * | 2008-04-02 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 尿膀胱癌抗原化学发光免疫分析定量测定试剂盒及其制备方法 |
CN101368958A (zh) * | 2008-04-02 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 乙型肝炎病毒核心抗体IgM化学发光免疫分析测定试剂盒 |
CN101368957A (zh) * | 2008-04-29 | 2009-02-18 | 北京科美东雅生物技术有限公司 | 谷氨酸脱羧酶抗体化学发光免疫分析测定试剂盒及其制备方法 |
CN102830235A (zh) * | 2012-08-28 | 2012-12-19 | 邹检平 | 一种发光检测试剂盒及其制备方法 |
CN102890083A (zh) * | 2012-09-28 | 2013-01-23 | 辽宁科骏生物有限公司 | 化学发光底物溶液和含其的试剂盒及应用其的检测方法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104711279A (zh) * | 2015-03-17 | 2015-06-17 | 北京一达启航生物科技有限公司 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
CN104711279B (zh) * | 2015-03-17 | 2018-03-02 | 山东一达启航生物科技有限公司 | 一种血管内皮生长因子检测试剂盒及其原料制备 |
CN107561287A (zh) * | 2017-08-30 | 2018-01-09 | 潍坊市康华生物技术有限公司 | 一种血管内皮细胞生长因子检测试剂盒及其制备和使用方法 |
CN108508198A (zh) * | 2018-06-21 | 2018-09-07 | 上海彧成生物科技有限公司 | 一种稳定的辣根过氧化物酶底物的配方 |
CN110082537A (zh) * | 2019-04-17 | 2019-08-02 | 迪瑞医疗科技股份有限公司 | 血管内皮生长因子化学发光免疫检测试剂盒及其制备方法 |
CN111044734A (zh) * | 2019-12-30 | 2020-04-21 | 上海复星长征医学科学有限公司 | 一种用于检测血管内皮生长因子的检测试剂盒及其制备方法和使用方法 |
CN111808191A (zh) * | 2020-05-11 | 2020-10-23 | 廊坊天光生物技术有限公司 | 一种用于检测血清中vegf含量的抗体对及其用途 |
CN113150157A (zh) * | 2020-05-11 | 2021-07-23 | 廊坊天光生物技术有限公司 | 一种用于检测血清中vegf含量的抗体对及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103969447A (zh) | 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液 | |
US20190323969A1 (en) | Zinc transporter 8 antibody chemiluminescence immunoassay kit and preparation method thereof | |
CN106199011A (zh) | 脂联素化学发光免疫检测试剂盒及其制备方法和应用 | |
CN101750492A (zh) | 自身免疫性肝炎检测蛋白芯片及其试剂盒 | |
CN101363860A (zh) | 梅毒螺旋体抗体化学发光免疫分析测定试剂盒及其制备方法 | |
CN107543932A (zh) | 一种降钙素的磁微粒化学发光检测试剂盒及制备方法 | |
CN102901812A (zh) | 一种人甲状腺球蛋白抗体(TGAb)的磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN106918708A (zh) | 一种用于检测胰岛素的竞争法胶乳增强免疫透射比浊试剂盒 | |
CN109187971A (zh) | 神经元特异性烯醇化酶化学发光免疫检测试剂盒及其制备方法 | |
CN104711279A (zh) | 一种血管内皮生长因子检测试剂盒及其原料制备 | |
CN109470857A (zh) | 免疫测定方法、用于鉴定免疫测定的系统和试剂盒 | |
CN109270272A (zh) | 一种检测抗突变型瓜氨酸化波形蛋白抗体的试剂盒及其制备方法 | |
CN107406510A (zh) | 前列腺抗原标准品及其用途 | |
CN106443018A (zh) | 一种肌红蛋白单克隆抗体酶标记复合及其制备方法和检测试剂盒 | |
CN108089005A (zh) | 一种磁微粒甲胎蛋白化学发光免疫检测试剂盒及其制备方法 | |
CN102226808A (zh) | 胰蛋白酶原-2化学发光免疫检测试剂盒及其制备方法 | |
CN109470861A (zh) | 免疫测定方法、用于鉴定免疫测定的系统和试剂盒 | |
CN101692085A (zh) | 定量检测人血清TRAb板式荧光酶免方法及其应用 | |
CN102890083B (zh) | 化学发光底物溶液和含其的试剂盒及应用其的检测方法 | |
Wunderlich et al. | A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin | |
CN106645756A (zh) | 一种检测nmp22的试剂盒及其制备方法 | |
CN110082537A (zh) | 血管内皮生长因子化学发光免疫检测试剂盒及其制备方法 | |
CN106290910A (zh) | 一种全程c‑反应蛋白的测试试剂盒及其检测方法 | |
CN110018156A (zh) | 抗CarP抗体作为系统性红斑狼疮诊断标志物的应用 | |
CN109298178A (zh) | 基于免疫磁珠的心脏肌球蛋白结合蛋白C(cMyBP-C)时间分辨荧光免疫分析试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG YIDA QIHANG BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG CONGCONG Effective date: 20141225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 053603 HENGSHUI, HEBEI PROVINCE TO: 266101 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141225 Address after: 266101, No. 1, building 57, No. 3 Haier Road, Laoshan District, Shandong, Qingdao Applicant after: Shandong Yida sailing Biological Technology Co., Ltd. Address before: 053603 Hengshui City, Hebei Province Anping County Cheng Xiang Zhang Village No. 183 oil Applicant before: Zhang Congcong |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140806 |
|
RJ01 | Rejection of invention patent application after publication |